Login to Your Account



Pharma: Other News To Note


Tuesday, November 19, 2013
• Teva Pharmaceutical Industries Ltd., of Jerusalem, said it added Lonquex (lipegfilgrastim), a long-acting G-CSF, and Granix (tbo-filgrastim), a short-acting G-CSF, to its oncology biologic portfolio.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription